MANFRINATO, Maria Cristina
 Distribuzione geografica
Continente #
NA - Nord America 4.013
EU - Europa 1.243
AS - Asia 978
Continente sconosciuto - Info sul continente non disponibili 8
AF - Africa 6
OC - Oceania 5
SA - Sud America 1
Totale 6.254
Nazione #
US - Stati Uniti d'America 3.994
CN - Cina 495
UA - Ucraina 295
IT - Italia 242
SG - Singapore 233
DE - Germania 187
GB - Regno Unito 143
TR - Turchia 143
FI - Finlandia 97
PL - Polonia 89
SE - Svezia 69
HK - Hong Kong 35
BE - Belgio 26
ID - Indonesia 24
CZ - Repubblica Ceca 19
CA - Canada 17
FR - Francia 17
NL - Olanda 15
IR - Iran 10
VN - Vietnam 10
ES - Italia 7
MY - Malesia 7
LT - Lituania 6
RO - Romania 6
SD - Sudan 6
BG - Bulgaria 5
IQ - Iraq 5
KR - Corea 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EU - Europa 4
IE - Irlanda 4
AU - Australia 3
IN - India 3
PT - Portogallo 3
GR - Grecia 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AL - Albania 1
AT - Austria 1
BR - Brasile 1
GE - Georgia 1
JP - Giappone 1
MK - Macedonia 1
MX - Messico 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
RU - Federazione Russa 1
Totale 6.254
Città #
Woodbridge 521
Fairfield 340
Jacksonville 330
Chandler 324
Houston 301
Ann Arbor 281
Santa Clara 269
Ashburn 206
Singapore 185
Wilmington 139
Ferrara 119
Cambridge 113
Nanjing 110
Seattle 107
Izmir 99
Beijing 88
Princeton 81
Warsaw 76
Boardman 66
Dearborn 57
Milan 44
Nanchang 37
Shanghai 37
San Diego 33
Shenyang 32
Hong Kong 31
Helsinki 30
Changsha 28
Brussels 26
Tianjin 25
Los Angeles 22
Bremen 19
Jakarta 19
Brno 18
Jiaxing 17
Hebei 16
Munich 15
Ningbo 15
Orange 15
Addison 14
Jinan 13
Norwalk 13
San Mateo 12
New York 11
Redwood City 11
Augusta 10
Mountain View 10
Auburn Hills 9
Dong Ket 9
Kraków 9
London 9
Washington 8
Des Moines 7
Falls Church 7
Frankfurt am Main 7
Leawood 7
Philadelphia 7
Bologna 6
Casalecchio Di Reno 6
Guangzhou 6
Montréal 6
Chicago 5
Indiana 5
Lübeck 5
Ottawa 5
Tappahannock 5
Wageningen 5
Ardabil 4
Dronten 4
Dublin 4
Düsseldorf 4
Ferrara di Monte Baldo 4
Fuzhou 4
Haikou 4
Khartoum 4
Rome 4
Shah Alam 4
Taizhou 4
Toronto 4
Zhengzhou 4
Calderara Di Reno 3
Changchun 3
Espoo 3
Hefei 3
Kunming 3
Las Vegas 3
Paris 3
Taipei 3
Tuen Mun 3
Verona 3
Amsterdam 2
Chisinau 2
Dolo 2
Hsinchu 2
Kuala Lumpur 2
Lanzhou 2
Madrid 2
Magelang 2
Melbourne 2
Razgrad 2
Totale 4.620
Nome #
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 166
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 161
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 158
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 134
Anomeric specificity and protein-substrate interactions support the 3D model for the hemagglutinin-neuraminidase from Sendai virus 132
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 132
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 131
null 128
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 119
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 114
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 111
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 110
null 110
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 106
null 104
Peptides derived from the heptad repeat region near the C-terminal of Sendai virus F protein bind the hemagglutinin-neuraminidase ectodomain 104
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 101
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 100
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 99
Thermal stability of the hemagglutinin-neuraminidase from Sendai virus evidences two folding domains 98
null 97
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 97
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 96
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 96
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 95
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 91
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 90
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 90
null 88
Substrate binding to 6-phosphogluconate dehydrogenase 88
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 85
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 84
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 84
Studies of Interaction between Sendai Virus Envelope Glycoproteins (HN ad F) by Syntetic peptides derived from the HR2 Region of the F Protein 82
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 78
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 77
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 77
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 76
Biochemical study in adult population with stroke in Ferrara, Fabry disease 76
Mutual communication of envelope glycoproteins of paramixoviruses 75
Limited preotolysis of cHN, the soluble hemagglutinin neuraminidase from sendai virus 73
Selective inhibition of Trypanosoma brucei 6-phosphogluconate dehydrogenase by high energy intermediate and transition state analogues 73
Conformational transitions during thermal inactivation of the neuraminidase from sendai virus 73
Catalytic mechanism of 6-phosphogluconate dehydrogenase investigated by site-directed mutagenesis 72
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 72
Domain structure of the hemagglutinin-neuraminidase from sendai virus 72
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 70
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 67
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 66
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 66
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 66
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 65
Enzymatic activation of NCX4016, a nitrate ester derivative of Aspirin 64
Purification of transglutaminase enzyme from L. infantum promastigotes 63
Partial unfolding of the hemagglutinin-neuraminidase from sendai virus 62
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 61
Xenobiotics biodegradation: recombinant DCM dehalogenase from alcaligenes xylosoxydans 60
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 60
Unfording and limited proteolysis of the hemagglutinin-neuraminidase from sendai virus 59
Synthetic peptides corresponding to the heptad repeat region of sendai virus fusion protein bind to the hemagglutinin-neuraminidase 59
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 59
Thermodynamic characterization of 6-phosphogluconate dehydrogenase ternary complex 59
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 58
Modulation of metalloproteinase-9 (MMP-9) by its specific tissue inhibitor (TIMP1) 55
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 55
null 53
inhibition of sendai virus fusion protein by interaction synthetic peptides derived F protein and hemagglutinin-neuraminidase 51
MMP-9 isoforms in serum of Multiple Sclerosis patients 50
The influence of different replacement solutions on neutrophils response 50
null 49
pH dependent structural changes of the hemagglutinin-neuraminidase from sendai virus 46
Decreased arylesterase activity of paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 36
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis 35
Vaginal Lactoferrin Administration Decreases Oxidative Stress in the Amniotic Fluid of Pregnant Women: An Open-Label Randomized Pilot Study 32
A Calcium- and GTP-Dependent Transglutaminase in Leishmania infantum 29
Effects of anticoagulants on the activity of gelatinases 28
Effects of anticoagulants on the activity of gelatinases 28
Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases 20
Influence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: beyond the pentose phosphate pathway 20
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study. 20
Lactoferrin administration prior to genetic amniocentesis dampens the intraamniotic inflammatory response 19
Differential pathogenicity and lethality of bubonic plague (1720–1945) by sex, age and place 16
Chemical and biological versatility of pyrazolo[3,4-d]pyrimidines: one scaffold, multiple modes of action 15
Active myeloperoxidase: a promising biomarker to differentiate “acute” and “low-grade” peri-prosthetic joint infections from aseptic failures 14
Influence of different strategies of volume replacement on the activity of metalloproteinases 9 12
Totale 6.372
Categoria #
all - tutte 30.831
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.831


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020621 0 0 0 0 0 130 103 108 84 120 55 21
2020/2021887 79 79 32 79 45 100 54 93 24 121 139 42
2021/2022639 21 70 26 21 27 25 19 25 19 71 45 270
2022/2023791 77 66 20 95 134 106 47 69 84 11 52 30
2023/2024407 42 48 16 15 61 40 10 24 17 12 8 114
2024/2025685 49 42 153 73 216 152 0 0 0 0 0 0
Totale 6.372